Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals.
about
HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.The role of viral co-infection in HIV-associated non-AIDS-related cancersCIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and TreatmentHIV DNA Is Frequently Present within Pathologic Tissues Evaluated at Autopsy from Combined Antiretroviral Therapy-Treated Patients with Undetectable Viral Loads.Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras.Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV/HCV-coinfected patients who achieved sustained virological response.Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study.HIV-positive men who have sex with men are at high risk of development of significant liver fibrosis after an episode of acute hepatitis C.The Role of Current and Historical Alcohol Use in Hepatic Fibrosis Among HIV-Infected Individuals.Poorly Controlled HIV Infection: An Independent Risk Factor for Liver Fibrosis.Food insecurity may lead to incomplete HIV viral suppression and less immune reconstitution among HIV/hepatitis C virus-coinfected people.End-Stage Liver Disease in HIV Infection: An Avoidable Burden?Hepatitis C coinfection adversely affects the life expectancy of people living with HIV in northwestern Poland.
P2860
Q36220953-8687A6AA-7CE1-4096-9869-E02773DCC4CFQ36960884-A6A1BE79-8B57-4D88-B2A3-EBE9C7261D30Q37100669-0C299D80-C813-428E-A374-EABF40C80A80Q37300347-513661F1-C831-48F7-802E-5B1DBD17D009Q38406226-99BF7347-06A8-44BA-9DE2-3A5F406F7E81Q38407281-9F224DA6-8610-4A0D-B41A-B049CBA626ECQ38946506-9FCA7652-8C5B-4C89-BB6D-7488929DC36BQ39171447-298153B8-294A-483C-8C89-510B99B998BBQ40109414-66AB0023-DA5A-42CD-BFB5-39A9E392941EQ40229182-1FBD8668-2DE4-4B3A-85A3-9F5486E106CCQ40390697-1C6E274A-B17D-4613-AFAA-1847FBEE190EQ40750320-1A33F271-FD60-4E8C-A1B1-DF07FB7C7969Q45325392-C74C6FC1-514E-4650-8F7A-8CCD93590221Q50777220-416608FC-FFF3-44E9-9C2F-C1537E14ED99Q55411140-B96F119A-E5D7-4D53-9882-58A3F5D2E637
P2860
Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Liver-related death among HIV/ ...... of directly acting antivirals.
@en
type
label
Liver-related death among HIV/ ...... of directly acting antivirals.
@en
prefLabel
Liver-related death among HIV/ ...... of directly acting antivirals.
@en
P2093
P50
P1433
P1476
Liver-related death among HIV/ ...... of directly acting antivirals.
@en
P2093
Aza Rakmanova
EuroSIDA in EuroCoord
Igor Karpov
Juergen K Rockstroh
Karine Lacombe
Lars Peters
Pere Domingo
Tatiana Trofimova
P304
P356
10.1097/QAD.0000000000000674
P407
P577
2015-06-01T00:00:00Z